Enzymatic synthesis of DHA-lysophosphatidylcholine and evaluation of its effect on the MDA-MB-231 human breast cancer cell line

This work studies the synthesis of DHA-lysophosphatidylcholine (LPC-DHA) by solvent-free lipase-catalyzed esterification and the ability of LPC-DHA to reduce cell viability of the human cancer cell line MDA-MB-231. Optimization of esterification parameters between glycerophosphatidylcholine (GPC) an...

Full description

Bibliographic Details
Main Author: Mohamad Ali, Dalal
Other Authors: Biologie des Organismes, Stress, Santé, Environnement Le Mans Université (BiOSSE), Le Mans Université (UM), Le Mans Université, Lionel Ulmann, Gaëlle Pencreac'h, Laurent Poisson
Format: Doctoral or Postdoctoral Thesis
Language:English
Published: HAL CCSD 2022
Subjects:
Online Access:https://theses.hal.science/tel-03934821
https://theses.hal.science/tel-03934821/document
https://theses.hal.science/tel-03934821/file/2022LEMA1003.pdf
Description
Summary:This work studies the synthesis of DHA-lysophosphatidylcholine (LPC-DHA) by solvent-free lipase-catalyzed esterification and the ability of LPC-DHA to reduce cell viability of the human cancer cell line MDA-MB-231. Optimization of esterification parameters between glycerophosphatidylcholine (GPC) and docosahexaenoic acid (DHA) was performed using response surface methodology (RSM). Two responses were measured: the conversion yield of GPC and the concentration of LPC-DHA in the medium. A GPC conversion yield of 67% is obtained under the following reaction conditions: a DHA/GPC molar ratio of 17, a reaction temperature of 36°C and a Novozym® 435 (immobilized lipase B from Candida antarctica) load of 15%. The maximum concentration of LPC-DHA obtained is 245 mM under the following conditions: a DHA/GPC molar ratio of 4, temperature of 36°C and a Novozym® 435 load of 15%. NMR characterization confirmed that the synthesized compound is pure and unoxidized sn-1 LPC-DHA In vitro study of the effect of different LPCs and different lipid vectors of DHA on MDA-MB-231 showed that LPC-DHA was the most effective in reducing cell viability, with IC50 for LPC-DHA, PC-DHA, MAG-DHA, and free DHA of 19 µM, 50 µM, 300 µM, and 347 µM, respectively. LPC-DHA and PC-DHA reduce cell viability primarily by inducing oxidative stress and plasma membrane damage. DHA and MAG-DHA also induced oxidative stress. In conclusion, this work led to the synthesis of LPC-DHA under favorable conditions and demonstrated the very interesting effect of LPC-DHA in reducing the viability of MDA-MB-231 breast cancer cells. Ce travail étudie la synthèse de DHA-lysophosphatidylcholine (LPC-DHA) par estérification enzymatique, catalysée par une lipase et sans solvant, ainsi que la capacité de la LPC-DHA à réduire la viabilité cellulaire de la lignée cancéreuse humaine MDA-MB-231. Une optimisation des paramètres de l’estérification entre la glycerophosphatidylcholine (GPC) et l’acide docosahexaénoïque (DHA, C22 :6 -3) a été réalisée selon la méthodologie des ...